Hospira's TheraDoc™ Infection Control Assistant Ranked #1 in Its Category in the Latest "Best in KLAS" Report

LAKE FOREST, Ill., Jan. 23, 2013 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced that its TheraDoc™ Infection Control Assistant™ has been ranked as the top product in the Infection Control & Monitoring software category in the recently released Best in KLAS Awards 2012: Software and Services Report (more information available at www.theradoc.com). The full report is available at www.KLASresearch.com. The rankings are based on data from customer surveys of North American hospital and clinic executives, administrators, physicians, nurses, clinicians, and other directors and managers interacting with healthcare equipment and infrastructure solutions.

TheraDoc Infection Control Assistant scored the highest overall performance rating in KLAS' Infection Control & Monitoring market segment, demonstrating excellence and leadership in serving customers and meeting their expectations. TheraDoc also received the highest product quality rating in its category, and the highest customer willingness to repurchase the software again (95 percent).[1]

"Hospira is honored that TheraDoc has been recognized for excellence in infection monitoring and surveillance software," said France Pitera, vice president, Clinical Information Technology, Hospira. "This recognition is very meaningful since it comes as a direct result of feedback from TheraDoc users. This close working relationship with our users is one key reason why 100 percent of the more than 600 hospitals and healthcare facilities nationwide that have acquired TheraDoc still retain the system today.*"

The TheraDoc clinical surveillance system helps infection preventionists tackle many of their most significant challenges, including time spent on regulatory reporting, time to identification of healthcare-associated infections (HAIs), time to isolation of patients with infectious diseases and tracking of organism resistance.

"After a thorough review of available systems, we chose TheraDoc to support our Infection Prevention program," says Peggy Thompson, R.N., B.S.N., C.I.C., director of Infection Prevention at Tampa General Hospital in Florida. "It has proven to be an invaluable tool in the ever-changing world of infections and regulatory requirements. TheraDoc staff is receptive and incorporates changes based on feedback from their customers." 

The TheraDoc Infection Control Assistant provides infection preventionists with real-time (a matter of seconds) information needed to make a valid identification of infections, while leaving final determination in the hands of infection preventionists. The Infection Control Assistant also delivers powerful tools enabling infection preventionists to configure workflow to their unique needs, develop their own alerts, select from a large library of existing alerts and automate creation of reports for the National Healthcare Safety Network.

As part of a suite of knowledge modules that make critical patient information and medical knowledge readily available, the Infection Control Assistant is designed to help clinicians intervene quickly, prescribe appropriately, and improve the quality and safety of patient care.[2],[3] The TheraDoc Clinical Intelligence™ Platform is the engine that powers these software modules, which also include the Antibiotic Assistant™, ADE Assistant™, Clinical Alerts Assistant™ and Anticoagulation Assistant™. For more information, visit www.theradoc.com.

KLAS is a research firm specializing in monitoring and reporting on the performance of healthcare vendors. KLAS' mission is to improve delivery by independently measuring vendor performance for the benefit of its healthcare provider partners, consultants, investors, and vendors. Working together with executives from more than 4,500 hospitals and more than 2,500 clinics, KLAS delivers timely reports, trends, and statistics that provide a solid overview of vendor performance in the industry. KLAS measures performance of software, professional services, medical equipment, and infrastructure vendors.

About Hospira
Hospira, Inc. is the world's leading provider of injectable drugs and infusion technologies. Through its broad, integrated portfolio, Hospira is uniquely positioned to Advance Wellness™ by improving patient and caregiver safety while reducing healthcare costs. The company is headquartered in Lake Forest, Ill., and has approximately 15,000 employees. Learn more at www.hospira.com.

*As of January 1, 2013. 

[1] "Best in KLAS Awards 2012: Software and Services Report," December 2012. © 2012 KLAS Enterprises, LLC. All rights reserved. www.KLASresearch.com.
[2] Hellinger W, Alvarez S, Brumble L, Keating M, Mendez J, Darracott R, Young E, Smith R, Mentel J. Optimizing antibiotic therapy with computerized integration of hospital information systems and an antibiotic management team (AMT). Poster session presented at: 42nd Annual Meeting of the Infectious Diseases Society of America; 2004 Sep 30-Oct 3; Boston, MA.
[3] Pass M, Song X, Mackie K, Perl T. Enhanced Isolation Practices To Improve Patient Safety: Preventing Nosocomial Transmission in a Hospital. Am J Infect Control. 2006 June;34(5):E105-E106.

SOURCE Hospira, Inc.

Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here